Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate

Japanese Journal of Cancer Research

Volumn 87, Issue 9, 1996, Pages 882-886

  Umemura, Takashi ^a   Hasegawa, Ryuichi ^a   Sai Kato, Kimie ^a   Nishikawa, Akiyoshi ^a   Furukawa, Fumio ^a   Toyokuni, Shinya ^b   Uchida, Koji ^c   Inoue, Tohru ^a   Kurokawa, Yuji ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

4 Hydroxy 2 nonenal; 8 Hydroxydeoxyguanosine; Ferric nitrilotriacetate; Mercaptoethane sulfonate; N acetylcysteine

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; ACETYLCYSTEINE; CELL NUCLEUS DNA; CREATININE; LIPID PEROXIDE; MESNA; NITRILOTRIACETATE IRON; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY CANCER; LIPID PEROXIDATION; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; UREA NITROGEN BLOOD LEVEL;

EID: 0029821355     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb02115.x     Document Type: Article

References (34)

1. Okada, S. and Midorikawa, S. Induction of rat renal adenocarcinoma by Fe-nitrilotriacetate (Fe-NTA). Jpn. Arch. Internal. Med., 29, 485-491 (1985) (in Japanese).
2. Hamazaki, S., Okada, S., Ebina, Y. and Midorikawa, S. Acute renal failure and glucosuria induced by ferric nitrilotriacetate in rats. Toxicol. Appl. Pharmacol., 77, 267-274 (1985).
3. Toyokuni, S., Uchida, K., Hattori-Nakakuki, Y., Hiai, H. and Stadtman, E. R. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc. Natl. Acad. Sci. USA, 91, 2616-2620 (1994).
4. Benedetti, A., Comporti, M. and Esterbauer, H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta, 620, 281-296 (1980).
5. Umemura, T., Sai, K., Takagi, A., Hasegawa, R. and Kurokawa, Y. Formation of 8-hydroxydeoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA). Carcinogenesis, 11, 345-347 (1990).
6. Umemura, T., Sai, K., Takagi, A., Hasegawa, R. and Kurokawa, Y. Oxidative DNA damage, lipid peroxidation and nephrotoxicity induced in the rat kidney after ferric nitrilotriacetate administration. Cancer Lett., 54, 95-100 (1990).
7. Toyokuni, S., Mori, T. and Dizdaroglu, M. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate, Int. J. Cancer, 57, 123-128 (1994).
8. Shibutani, S., Takeshita, M. and Grollman, A. P. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxo-dG. Nature, 349, 431-434 (1991).
9. Kamiya, H., Miura, K., Ishikawa, H., Nishimura, S. and Ohtsuka, E. c-Ha-ras containing 8-hydroxydeoxyguanine at codon 12 induces point mutations at the modified and adjacent positions. Cancer Res., 52, 3483-3485 (1992).
10. Katz, A., Epelman, S., Anelli, A., Gorender, E. F., Cruz, S. M., Olivelia, R. M. and Marques, L. A. A prospective randomized evaluation of three schedules of mesna administration in patients receiving an ifosfamide-containing chemotherapy regimen: sustained efficiency and simplified administration. J. Cancer Res. Clin. Oncol., 121, 128-131 (1995).
11. Ormstad, K., Orrenius, S., Lastbom, T., Uehara, N., Pohl, J. and Brock, N. Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat. Cancer Res., 43, 333-338 (1983).
12. Bongers, V., Jong, D. J., Vries, N. D., Bast, A., Snow, G. B. and Braakhuis, B. J. M. Antioxidant-related parameters in patients treated for cancer chemoprevention with N-acetylcysteine. Eur. J. Cancer, 31A, 921-923 (1995).
13. Awai, M., Narasaki, M., Yamanoi, Y. and Seno, S. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. Am. J. Pathol., 95, 663-672 (1979).
14. 3) carcinogenesis. Carcino-genesis, 16, 593-597 (1995).
15. Uchiyama, M. and Mihara, M. Determination of malonaldehyde precursor in tissue by the thiobarbituric acid test. Anal. Biochem., 86, 271-278 (1978).
16. Uchida, K., Szweda, L. I., Chae, H.-Z. and Stadtman, E. R. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc. Natl. Acad. Sci. USA, 90, 8742-8746 (1993).
17. Tsai, L. and Sokoloski, E. A. The reaction of 4-hydroxy-2-nonenal with Nα-acetyl-L-histidine. Free Rad. Biol. Med., 19, 39-44 (1995).
18. Uchida, K., Fukuda, A., Kawakishi, S., Hiai, H. and Toyokuni, S. A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney. Arch. Biochem. Biophys., 317, 405-411 (1995).
19. Wood, M. L., Dizdaroglu, M., Gajewski, E. and Essignmann, J. M. Mechanistic studies of ionizing irradiation and oxidative mutagenesis: genetic effects of 8-hydroxyguanine (8-oxoguanine) residue inserted at a unique site in a viral genome. Biochemistry, 29, 7024-7032 (1990).
20. Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S. and Loeb, L. A. 8-Hydroxydeoxyguanosine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J. Biol. Chem., 267, 166-172 (1992).
21. Takagi, A., Sai, K., Umemura, T., Hasegawa, R. and Kurokawa, Y. Inhibitory effects of vitamin E and ellagic acid on 8-hydroxydeoxyguanosine formation in liver nuclear DNA of rats treated with 2-nitropropane. Cancer Lett., 91, 139-144 (1995).
22. Sai-Kato, K., Takagai, A., Umemura, T., Hasegawa, R. and Kurokawa, Y. Role of oxidative stress in non-genotoxic carcinogenesis with special reference to liver tumors induced by peroxisome proliferators. Biomed. Environ. Sci., 8, 269-279 (1995).
23. Umemura, T., Sai-Kato, K., Takagi, A., Hasegawa, R. and Kurokawa, Y. Oxidative DNA damage and cell proliferation in the livers of B6C3F1 mice exposed to pentachlorophenol in their diet. Fundam. Appl. Toxicol., 30, 285-289 (1996).
24. Akiyama, T., Hamazaki, S. and Okada, S. Absence of ras mutations and low incidence of p53 mutations in renal cell carcinomas induced by ferric nitrilotriacetate. Jpn. J. Cancer Res., 86, 1143-1149 (1995).
25. Winter, C. K., Segall, H. J. and Haddon, W. F. Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. Cancer Res., 46, 5682-5686 (1986).
26. Chung, F. L., Chen, H.-J. C., Guttenplan, J. B., Nishikawa, A. and Hard, G. C. 2,3-Epoxy-4-hydroxynonanal as a potential tumor-initiating agent of lipid peroxidation. Carcinogenesis, 14, 2073-2077 (1993).
27. Izzoti, A., Balansky, R., Scatolini, L., Rovida, A. and Flora, S. D. Inhibition by N-acetylcysteine of carcinogen-DNA adducts in the tracheal epithelium of rats exposed to cigarette smoke. Carcinogenesis, 16, 669-672 (1995).
28. Wang, M., Nishikawa, A. and Cheung, F. L. Differential effects of thiols on DNA modifications via alkylation and Michael addition by α-acetoxy-N-nitrosopyrrolidine. Chem. Res. Toxicol., 5, 528-531 (1992).
29. Ormstad, K. and Ohno, Y. N-Acetylcysteine and sodium 2-mercaptoethane sulfonate as sources of urinary thiol groups in the rat. Cancer Res., 44, 3797-3800 (1984).
30. Spear, N. and Aust, S. D. Thio-mediated NTA-Fe(III) reduction and lipid peroxidation. Arch. Biochem. Biophys., 312, 198-202 (1994).
31. Hamazaki, S., Okada, S., Toyokuni, S. and Midorikawa, O. Thiobarbituric acid-reactive substance formation of rat kidney brush border membrane vesicles induced by ferric nitrilotriacetate. Arch. Biochem. Biophys., 274, 348-354 (1989).
32. Umemura, T., Sai, K., Takagi, A., Hasegawa, R. and Kurokawa, Y. The effects of exogenous glutathione and cysteine on oxidative stress induced by ferric nitrilotriacetate. Cancer Lett., 58, 49-56 (1991).
33. Okada, S., Minamiyama, Y., Hamazaki, S., Toyokuni, S. and Sotomatsu, A. Glutathione cycle dependency of ferric nitrilotriacetate-induced lipid peroxidation in mouse proximal renal tubules. Arch. Biochemist. Biophys., 301, 138-142 (1993).
34. Okamoto, K., Toyokuni, S., Uchida, K., Ogawa, O., Takenewa, J., Kakehi, Y., Kinoshita, H., Hattori-Nakakuki, Y., Hiai, H. and Yoshida, O. Formation of 8-hydroxy-2′-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int. J. Cancer, 58, 825-829 (1994).